Hans van der Lelie

Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

Thierry Philip, Cesare Guglielmi, Anton Hagenbeek et al. · New England Journal of Medicine · 1995 · 2.4K citations

Medicine, Hematology, Oncology +14

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Jan J. Cornelissen, Wim L.J. van Putten, Leo F. Verdonck et al. · Blood · 2007 · 470 citations · Full text

Medicine, Hematology, Oncology +17

Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections

Alexander C. A. P. Leenders, Simon Daenen, Rob L. H. Jansen et al. · British Journal of Haematology · 1998 · 321 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.

Pieter Sonneveld, Maria de Ridder, Hans van der Lelie et al. · Journal of Clinical Oncology · 1995 · 279 citations

Medicine, Oncology, Pharmacology +14

Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial.

Cesare Guglielmi, F. Gómez, Thierry Philip et al. · Journal of Clinical Oncology · 1998 · 157 citations

Medicine, Oncology, Chemotherapy +14